Involvement of RFC3 in tamoxifen resistance in ER-positive breast cancer through the cell cycle-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Involvement of RFC3 in tamoxifen resistance in ER-positive breast cancer through the cell cycle

Published:2023-12-06 Issue:23 Volume:15 Page:13738-13752
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Zhu Jintao¹,Ye Lei²,Sun Shishen²,Yuan Jie³,Huang Jianfeng³,Zeng Zhiqiang¹

Affiliation:

1. Department of Breast, Foshan Fosun Chancheng Hospital, Foshan, Guangdong, China

2. Foshan Clinical Medical School of Guangzhou University of Chinese Medicine, Foshan, Guangdong, China

3. Department of General Surgery, Foshan Fosun Chancheng Hospital, Foshan, Guangdong, China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Reference36 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries.;Bray;CA Cancer J Clin,2021

2. A three-gene model to robustly identify breast cancer molecular subtypes.;Sotiriou;J Natl Cancer Inst,2012

3. Personalizing the treatment of women with early breast cancer: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2013.;Senn;Ann Oncol,2013

4. 4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†.;Cardoso;Ann Oncol,2018

5. Overcoming Endocrine Resistance in Breast Cancer.;Arteaga;Cancer Cell,2020

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP